Merck is using adaptive clinical trial designs to shorten the time-to-market for new drugs by combining study phases. This complex methodology creates a need for advanced data analytics, statistical modeling software, and process automation tools to manage the trials effectively and reduce development timelines.
Filing excerpt
Another type of adaptive clinical trial is an adaptive Phase 2/3 trial design, a study that includes an interim analysis and an adaptation that changes the trial from having features common in a Phase 2 study (e.g., multiple dose groups) to a design similar to a Phase 3 trial.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-10kautomationInvestmentGet every 10-K signal for Merck and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Merck this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/f41ed92d-f67a-45a4-b39a-fee39abfbfa4 returns this record as JSON. POST /v1/companies/enrich returns every signal for merck.com.
{
"signal_id": "f41ed92d-f67a-45a4-b39a-fee39abfbfa4",
"signal_type": "sec-10k",
"signal_subtype": "automationInvestment",
"detected_at": "2026-03-03T05:49:01.153+00:00",
"company": {
"name": "Merck",
"domain": "merck.com"
},
"data": {
"detail": "Merck is using adaptive clinical trial designs to shorten the time-to-market for new drugs by combining study phases. This complex methodology creates a need for advanced data analytics, statistical modeling software, and process automation tools to manage the trials effectively and reduce development timelines.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Adopting adaptive Phase 2/3 trial designs to accelerate drug development timelines.",
"excerpts": "Another type of adaptive clinical trial is an adaptive Phase 2/3 trial design, a study that includes an interim analysis and an adaptation that changes the trial from having features common in a Phase 2 study (e.g., multiple dose groups) to a design similar to a Phase 3 trial.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/mrk-20251231.htm",
"filing_date": "2026-02-24",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Automation vendor opportunity",
"signal_category": "technology",
"technologies_mentioned": [
"adaptive design methodology"
]
}
}
curl https://signals.autobound.ai/v1/signals/f41ed92d-f67a-45a4-b39a-fee39abfbfa4 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"merck.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.